Trump Administration Imposes New Restrictions on Fetal Tissue Research

June 5, 2019 by Dan McCue

The Trump administration announced Wednesday that it will sharply reduce the amount of federal money supporting medical research that relies on tissue from aborted fetuses, handing a significant victory to anti-abortion groups who had lobbied for such a decision for years.

In a statement posted to its website Wednesday afternoon, the U.S. Department of Health and Human Services said it is immediately ending a $2 million-a-year program with the University of California, San Francisco, for research using fetal tissue from elective abortions.

The department went on to say that based on a review that began last fall, it is also ending about 200 research projects conducted by federal scientists at the National Institutes of Health that involve fetal tissue from elective abortions.

In announcing the changes, HHS explained that “promoting the dignity of human life from conception to natural death is one of the very top priorities of President Trump’s administration.”

In addition to unveiling the new restrictions, the department said it is continuing to conduct a comprehensive review of all research involving fetal tissue “to ensure consistency with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved.”

It also said it will carry out ethics reviews on government-funded research at universities and other scientific centers that propose to use fetal tissue.

Federal funding of such research became a hot-button issue four years ago after a group opposed to a woman’s right to make her own health decisions, released videos purportedly showing Planned Parenthood profiting from sale of the tissues.

Planned Parenthood sued, contending the videos were edited to be intentionally misleading, and a Texas grand jury subsequently cleared the agency of any wrongdoing.

On Wednesday, the group behind the videos, the Center for Medical Progress, released a statement saying “President Trump is showing transformative leadership by directing his pro-life administration to end the unconscionable taxpayer funding of fetal experimentation.

“Americans across the country are experiencing a revolution of consciousness about the human atrocity of industrial-scale, taxpayer-funded abortion and infanticide. Now is the time for the U.S. Department of Justice and regulatory authorities to hold entities like Planned Parenthood who traffic in aborted baby body parts accountable under the law,” the group said.

Meanwhile Jeanne Mancini, president of March for Life, another anti-abortion group, said “most Americans do not want their tax dollars creating a marketplace for aborted baby body parts which are then implanted into mice and used for experimentation.

“This type of research involves the gross violation of basic human rights and certainly the government has no business funding it,” Mancini said.

But in an interview with The New York Times, Lawrence Gusting, a professor of public health law at Georgetown University, said the administration’s actions on Wednesday would “devastate” critical medical research.

“It will affect everything from cures for cancer and H.I.V. through to Parkinson’s and dementia,” Gusting told the Times. “The ban on fetal tissue research is akin to a ban on hope for millions of Americans suffering from life threatening and debilitating diseases.

“It will also severely impact the National Institutes of Health, universities, and other researchers, who will lose key funding for their laboratories and their vital work,” he said.

Science

SpaceX Capsule and NASA Crew Make 1st Splashdown in 45 years
Space
SpaceX Capsule and NASA Crew Make 1st Splashdown in 45 years

CAPE CANAVERAL, Fla. (AP) — Two NASA astronauts returned to Earth on Sunday in a dramatic, retro-style splashdown, their capsule parachuting into the Gulf of Mexico to close out an unprecedented test flight by Elon Musk's SpaceX company. It was the first splashdown by U.S. astronauts... Read More

Cognitive Testing, Politics, and the Very Real Issue of Alzheimer's Disease and Dementia
Mental Health
Cognitive Testing, Politics, and the Very Real Issue of Alzheimer's Disease and Dementia
July 30, 2020
by Dan McCue

WASHINGTON - For weeks it had been the stuff of living room banter and fodder for self-quarantining late night comedians. Suddenly, apparently on a whim, the president who once described himself as a "very stable genius," was talking about how he "aced" a mental fitness test.... Read More

The More We Stay Home, The Less the Coronavirus Spreads. Here’s the Evidence
Health
The More We Stay Home, The Less the Coronavirus Spreads. Here’s the Evidence

Remember when you decided against a trip to the dog park, a meet-up at a sports bar, or a visit to your sister’s house? New research shows that such social distancing decisions mattered back in April, when the coronavirus was still expanding its reach across the... Read More

FDA Issues Draft Guidance on Cannabis Research
In The News
FDA Issues Draft Guidance on Cannabis Research
July 22, 2020
by Dan McCue

WASHINGTON - The Food and Drug Administration issued a draft guidance establishing rules for lawfully researching cannabis. The guidance is limited to the development of drugs and does not cover other FDA-regulated products. Nevertheless, the release of the document and publication of a Federal Register notice... Read More

Look Out, Mars: Here We Come With a Fleet of Spacecraft
Space
Look Out, Mars: Here We Come With a Fleet of Spacecraft

CAPE CANAVERAL, Fla. (AP) — Mars is about to be invaded by planet Earth — big time. Three countries — the United States, China and the United Arab Emirates — are sending unmanned spacecraft to the red planet in quick succession beginning this week, in the... Read More

FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
Health
FDA Issues Guidance on Development of a Safe and Effective COVID-19 Vaccine
June 30, 2020
by Dan McCue

WASHINGTON - The U.S. Food and Drug Administration released a series of recommendations Tuesday that it say should help facilitate the timely development of a safe and effective COVID-19 vaccine. The agency said the guidance reflects advice it has been providing over the "past several months"... Read More

News From The Well
scroll top